Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06389292
Status:
RECRUITING
Last Update Posted:
2024-04-29
First Post:
2024-04-24
Brief Title:
A Pivotal Study of APG-2575 Lisaftoclax Combined With Azacytidine in the Treatment of Acute Myeloid Leukemia
Sponsor:
Ascentage Pharma Group Inc
Organization:
Ascentage Pharma Group Inc
Organization Data
Organization:
Ascentage Pharma Group Inc
Class:
INDUSTRY
Study ID:
APG2575AG301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ascentage Pharma Group Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None